Carl Zeiss Meditec AG (ETR:AFX – Get Free Report) shares dropped 0.1% on Monday . The company traded as low as €53.75 ($56.58) and last traded at €54.85 ($57.74). Approximately 241,302 shares traded hands during trading, an increase of 156% from the average daily volume of 94,405 shares. The stock had previously closed at €54.90 ($57.79).
Carl Zeiss Meditec Stock Performance
The firm has a market capitalization of $5.11 billion, a PE ratio of 29.31, a price-to-earnings-growth ratio of 2.83 and a beta of 0.98. The company has a current ratio of 2.13, a quick ratio of 2.47 and a debt-to-equity ratio of 7.41. The business’s 50 day simple moving average is €50.98 and its two-hundred day simple moving average is €57.64.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Featured Articles
- Five stocks we like better than Carl Zeiss Meditec
- Stock Sentiment Analysis: How it Works
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- 10 Best Airline Stocks to Buy
- Conflicting Signals: Tempus AI’s Stock Market Rally
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
